Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher S Foster

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
The American Journal of Surgical Pathology|December 6, 2003
Declining estrogen receptor-beta expression defines malignant progression of human breast neoplasiaAbeer M Shaaban, Penny A O'Neill, Michael P A Davies, et al.
Prostate Cancer and Prostatic Diseases|March 22, 2019
Anti-metastatic effect of ranolazine in an in vivo rat model of prostate cancer, and expression of voltage-gated sodium channel protein in human prostateIlknur Bugan, Selma Kucuk, Zeynep Karagoz, et al.
Oncogene|May 14, 2003
High-level expression of cutaneous fatty acid-binding protein in prostatic carcinomas and its effect on tumorigenicityJanet Adamson, Elwin A Morgan, Carol Beesley, et al.
International Journal of Oncology|March 25, 2008
Expression of cutaneous fatty acid-binding protein (C-FABP) in prostate cancer: potential prognostic marker and target for tumourigenicity-suppressionElwin A Morgan, Shiva S Forootan, Janet Adamson, et al.
International Journal of Oncology|November 6, 2013
The expression of C-FABP and PPARγ and their prognostic significance in prostate cancerFarzad S Forootan, Shiva S Forootan, Mohammed I Malki, et al.
Virchows Archiv : an International Journal of Pathology|September 10, 2010
Measurements of cancer extent in a conservatively treated prostate cancer biopsy cohortRamzi Rajab, Gabrielle Fisher, Michael W Kattan, et al.
Genes & Cancer|October 30, 2013
A novel cutaneous Fatty Acid-binding protein-related signaling pathway leading to malignant progression in prostate cancer cellsZhengzheng Bao, Mohammad I Malki, Shiva S Forootan, et al.
BMC Cancer|September 7, 2014
DNA methylation gene-based models indicating independent poor outcome in prostate cancerNataša Vasiljević, Amar S Ahmad, Mangesh A Thorat, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 14, 2010
An improved prognostic model for stage T1a and T1b prostate cancer by assessments of cancer extentRamzi Rajab, Gabrielle Fisher, Michael W Kattan, et al.
Cancer|November 15, 2007
Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intentMichael W Kattan, Jack Cuzick, Gabrielle Fisher, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
The American Journal of Surgical Pathology|December 6, 2003
Declining estrogen receptor-beta expression defines malignant progression of human breast neoplasiaAbeer M Shaaban, Penny A O'Neill, Michael P A Davies, et al.
Prostate Cancer and Prostatic Diseases|March 22, 2019
Anti-metastatic effect of ranolazine in an in vivo rat model of prostate cancer, and expression of voltage-gated sodium channel protein in human prostateIlknur Bugan, Selma Kucuk, Zeynep Karagoz, et al.
Oncogene|May 14, 2003
High-level expression of cutaneous fatty acid-binding protein in prostatic carcinomas and its effect on tumorigenicityJanet Adamson, Elwin A Morgan, Carol Beesley, et al.
International Journal of Oncology|March 25, 2008
Expression of cutaneous fatty acid-binding protein (C-FABP) in prostate cancer: potential prognostic marker and target for tumourigenicity-suppressionElwin A Morgan, Shiva S Forootan, Janet Adamson, et al.
International Journal of Oncology|November 6, 2013
The expression of C-FABP and PPARγ and their prognostic significance in prostate cancerFarzad S Forootan, Shiva S Forootan, Mohammed I Malki, et al.
Virchows Archiv : an International Journal of Pathology|September 10, 2010
Measurements of cancer extent in a conservatively treated prostate cancer biopsy cohortRamzi Rajab, Gabrielle Fisher, Michael W Kattan, et al.
Genes & Cancer|October 30, 2013
A novel cutaneous Fatty Acid-binding protein-related signaling pathway leading to malignant progression in prostate cancer cellsZhengzheng Bao, Mohammad I Malki, Shiva S Forootan, et al.
BMC Cancer|September 7, 2014
DNA methylation gene-based models indicating independent poor outcome in prostate cancerNataša Vasiljević, Amar S Ahmad, Mangesh A Thorat, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 14, 2010
An improved prognostic model for stage T1a and T1b prostate cancer by assessments of cancer extentRamzi Rajab, Gabrielle Fisher, Michael W Kattan, et al.
Cancer|November 15, 2007
Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intentMichael W Kattan, Jack Cuzick, Gabrielle Fisher, et al.
Pageof 8